Is thromboelastography (TEG)-based resuscitation better than empirical 1:1 transfusion?
|dc.description.abstract||Thomboelastography (TEG) is a whole blood measure of coagulation which was originally described in the 1950s. However, it has only been in the last few decades that assays have become accessible and viable as a point-of-care test. Following the observation that hemorrhagic shock is associated with an intrinsic coagulopathy, TEG has been used as a method of diagnosing specific coagulation defects in order to direct individualized blood products resuscitation. An alternative transfusion strategy is the administration of fixed ratio products, a paradigm borne out of military experience. It is unknown which strategy is superior and this topic was debated at the 36th Annual Point/Counterpoint Acute Care Surgery Conference. The following article summarizes the discussants points of view along with a summary of the evidence.Level of Evidence Level III. Copyright Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved.||en_US|
|dc.publisher||BMJ Publishing Group||en_US|
|dc.relation.ispartof||Trauma Surgery and Acute Care Open|
|dc.title||Is thromboelastography (TEG)-based resuscitation better than empirical 1:1 transfusion?||en_US|